Venture capital fund · 5 deals
Monash University's new venture investing identity
Every published round Monash Ventures took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| All G Foods | Seed | Sep 2021 | $16m | Participant | Startup Daily (30 May 2024), Startup Daily (24 Oct 2023), AgFunderNews, Startup Daily (14 Feb 2022) | |
| Fyton Bio | Pre-seed | 4 Aug 2025 | $1m | Participant | @AuManufacturing (11 Aug 2025), @AuManufacturing (1 Aug 2025), Breakthrough Victoria | |
| Myostellar | Pre-seed | 4 Aug 2025 | $750k | Participant | @AuManufacturing (11 Aug 2025), Breakthrough Victoria (4 Aug 2025), @AuManufacturing (1 Aug 2025), Breakthrough Victoria (1 Aug 2025) | |
| RAGE Biotech | Series A | 14 Nov 2025 | $29m | Participant | Startup Daily, SmartCompany | |
| Remagine Labs | Pre-seed | 4 Aug 2025 | $500k | Participant | @AuManufacturing (11 Aug 2025), @AuManufacturing (1 Aug 2025), Breakthrough Victoria |
Companies Monash Ventures has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| All G Foods | Sep 2021, Seed | 1 | 0 | |
| Fyton Bio | Working on antibody therapies to target and eliminate disease-causing immune cells in aut… | 4 Aug 2025, Pre-seed | 1 | 0 |
| Myostellar | Developing a biologic therapy for Duchenne Muscular Dystrophy that promotes muscle regene… | 4 Aug 2025, Pre-seed | 1 | 0 |
| RAGE Biotech | Therapeutics startup developing an inhaled treatment for chronic lung disease | 14 Nov 2025, Series A | 1 | 0 |
| Remagine Labs | Wearable electronically controlled drug delivery device startup | 4 Aug 2025, Pre-seed | 1 | 0 |
Fund closes reported for Monash Ventures, as distinct from the investments it has made.
| Fund | Announced | Committed | Target | Close | Sources |
|---|---|---|---|---|---|
| Monash Ventures Pre-Seed Fund | 1 Aug 2025 | $15m | - | - | @AuManufacturing, SmartCompany, Breakthrough Victoria |
Companies Monash Ventures has backed that another company then bought. An exit for the holding, not a deal Monash Ventures did.
Stories naming Monash Ventures. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Skalata's rebrand announcement explains its shift to year-round seed investing, wider cheque sizes and follow-on plans, recaps team hires including a Venture Partner and three associates, and notes portfolio companies' Series A raises.
Breakthrough Victoria reports investing in xCystence Bio, a Monash University spinout developing polycystic kidney disease therapies, via its University Innovation Platform alongside BioCurate and UniSeed.
Also Uniseed
Weekly roundup of eight raises totalling $572.12 million, led by Firmus's $500 million round; RAGE Biotech, SunDrive, Number 8 Bio, Fabra, Keeyu, MyGig and Drone-Hand also funded, plus two RAGE Biotech executive appointments.
Also SmartCompany·Startup Daily·Startup Daily·Startup Daily·Startup Daily·Startup Daily·Business News Australia
Melbourne biotech RAGE Biotech has raised a $29 million Series A, with IP Group Australia and Hostplus leading, to fund human trials of its lung disease therapy; new executives were appointed.
Also Startup Daily
Blackbird's investment note recapping its backing of Coherence Neuro and the neural implant startup's development milestones, institutional collaborations, and path toward first-in-human glioblastoma trials.
Uniseed chief executive Peter Devine departs after two decades; Monash's Alistair Hick takes over in 2026. The piece recounts Uniseed's fund history and recent stakes in ENA Respiratory and Morse Micro rounds.
Weekly roundup: Breakthrough Victoria and Monash University co-invest $2.25 million across three university healthtech spinouts, while Blackbird backs Hall, which helps businesses win visibility on AI platforms, with $2 million pre-seed.
Also Startup Daily
Breakthrough Victoria and Monash University put joint pre-seed backing into three life-sciences spinouts and launched the $15m Monash Ventures pre-seed fund, part of a $100m platform commercialising Victorian university research.
The investor's site reports a joint pre-seed investment with Monash University totalling $2.25 million across three health startups, and the launch of Monash Ventures' $15 million pre-seed fund for research commercialisation.
Also Breakthrough Victoria·SmartCompany·@AuManufacturing·@AuManufacturing
Meliora, Clive Dickens' advisory firm, has started backing AI companies alongside a student-focused venture fund that is closing in on its fundraising target.
Also Forbes Australia
Breakthrough Victoria defends its spending and investment record against critics urging its abolition, pointing to portfolio companies, university partnerships and recent backing of startups including Aravax.
Woolworths' corporate venture arm W23 has added an undisclosed multi-million-dollar investment to its backing of Sydney alt-protein maker All G Foods, which had earlier raised a $16 million seed round in late 2021.
Also AgFunderNews·@AuManufacturing·SmartCompany·Startup Daily·Startup Daily·AgFunderNews